Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04SPO
|
||||
| Former ID |
DNC010274
|
||||
| Drug Name |
E-6-O-p-methoxycinnamoyl scandoside methyl ester
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530569] | ||
| Formula |
C27H32O13
|
||||
| Canonical SMILES |
COC1=CC=C(C=C1)C=CC(=O)OC2C=C(C3C2C(=COC3OC4C(C(C(C(O4)<br />CO)O)O)O)C(=O)OC)CO
|
||||
| InChI |
1S/C27H32O13/c1-35-15-6-3-13(4-7-15)5-8-19(30)38-17-9-14(10-28)20-21(17)16(25(34)36-2)12-37-26(20)40-27-24(33)23(32)22(31)18(11-29)39-27/h3-9,12,17-18,20-24,26-29,31-33H,10-11H2,1-2H3/b8-5+/t17-,18-,20-,21+,22-,23+,24-,26+,27+/m1/s1
|
||||
| InChIKey |
VBHBNHXZBKWQNO-BIIYMWGFSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Leukocyte elastase | Target Info | Inhibitor | [530569] | |
| Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
| C-MYB transcription factor network | |||||
| References | |||||